PortfoliosLab logoPortfoliosLab logo
MELIX vs. GMAQX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MELIX vs. GMAQX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Morgan Stanley Institutional Fund, Inc. Emerging Markets Leaders Portfolio (MELIX) and GMO Emerging Markets ex-China Fund (GMAQX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MELIX achieves a 12.95% return, which is significantly lower than GMAQX's 57.96% return.


MELIX

1D
0.37%
1M
5.78%
YTD
12.95%
6M
11.55%
1Y
19.24%
3Y*
10.93%
5Y*
-1.47%
10Y*
7.96%

GMAQX

1D
1.05%
1M
28.51%
YTD
57.96%
6M
64.09%
1Y
93.54%
3Y*
34.94%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MELIX vs. GMAQX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
MELIX
Morgan Stanley Institutional Fund, Inc. Emerging Markets Leaders Portfolio
12.95%10.61%2.24%12.17%-33.49%-7.10%
GMAQX
GMO Emerging Markets ex-China Fund
57.96%32.09%0.62%27.41%-32.38%0.47%

Correlation

The correlation between MELIX and GMAQX is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.78

Correlation (3Y)
Calculated over the trailing 3-year period

0.77

Correlation (All Time)
Calculated using the full available price history since Oct 19, 2021

0.75

The correlation between MELIX and GMAQX has been stable across timeframes, ranging from 0.75 to 0.78 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MELIX vs. GMAQX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MELIX
MELIX Risk / Return Rank: 1515
Overall Rank
MELIX Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
MELIX Sortino Ratio Rank: 1414
Sortino Ratio Rank
MELIX Omega Ratio Rank: 1616
Omega Ratio Rank
MELIX Calmar Ratio Rank: 1414
Calmar Ratio Rank
MELIX Martin Ratio Rank: 1616
Martin Ratio Rank

GMAQX
GMAQX Risk / Return Rank: 9797
Overall Rank
GMAQX Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
GMAQX Sortino Ratio Rank: 9797
Sortino Ratio Rank
GMAQX Omega Ratio Rank: 9797
Omega Ratio Rank
GMAQX Calmar Ratio Rank: 9797
Calmar Ratio Rank
GMAQX Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MELIX vs. GMAQX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley Institutional Fund, Inc. Emerging Markets Leaders Portfolio (MELIX) and GMO Emerging Markets ex-China Fund (GMAQX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MELIXGMAQXDifference
Sharpe ratioReturn per unit of total volatility

-3.44

Sortino ratioReturn per unit of downside risk

-4.46

Omega ratioGain probability vs. loss probability

1.20

1.94

-0.73

Calmar ratioReturn relative to maximum drawdown

1.25

6.82

-5.57

Martin ratioReturn relative to average drawdown

4.52

26.25

-21.73

MELIX vs. GMAQX - Sharpe Ratio Comparison

The current MELIX Sharpe Ratio is 1.08, which is lower than the GMAQX Sharpe Ratio of 4.51. The chart below compares the historical Sharpe Ratios of MELIX and GMAQX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MELIXGMAQXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.08

4.51

-3.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.41

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.81

-0.45

Drawdowns

MELIX vs. GMAQX - Drawdown Comparison

The maximum MELIX drawdown since its inception was -46.84%, which is greater than GMAQX's maximum drawdown of -41.97%. Use the drawdown chart below to compare losses from any high point for MELIX and GMAQX.


Loading charts...

Drawdown Indicators


MELIXGMAQXDifference

Max Drawdown

Largest peak-to-trough decline

-46.84%

-41.97%

-4.87%

Max Drawdown (1Y)

Largest decline over 1 year

-15.14%

-13.77%

-1.37%

Max Drawdown (3Y)

Largest decline over 3 years

-21.85%

-19.64%

-2.21%

Max Drawdown (5Y)

Largest decline over 5 years

-44.63%

Max Drawdown (10Y)

Largest decline over 10 years

-46.84%

Current Drawdown

Current decline from peak

-18.30%

0.00%

-18.30%

Average Drawdown

Average peak-to-trough decline

-17.86%

-16.74%

-1.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.16%

3.57%

+0.59%

Volatility

MELIX vs. GMAQX - Volatility Comparison

The current volatility for Morgan Stanley Institutional Fund, Inc. Emerging Markets Leaders Portfolio (MELIX) is 6.40%, while GMO Emerging Markets ex-China Fund (GMAQX) has a volatility of 12.47%. This indicates that MELIX experiences smaller price fluctuations and is considered to be less risky than GMAQX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MELIXGMAQXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.40%

12.47%

-6.07%

Volatility (6M)

Calculated over the trailing 6-month period

15.63%

18.53%

-2.90%

Volatility (1Y)

Calculated over the trailing 1-year period

17.55%

20.81%

-3.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.55%

17.22%

+2.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.64%

17.22%

+2.42%

MELIX vs. GMAQX - Expense Ratio Comparison

MELIX has a 1.15% expense ratio, which is higher than GMAQX's 0.67% expense ratio.


Dividends

MELIX vs. GMAQX - Dividend Comparison

MELIX has not paid dividends to shareholders, while GMAQX's dividend yield for the trailing twelve months is around 5.97%.


PositionTTM20252024202320222021202020192018201720162015
GMAQX
GMO Emerging Markets ex-China Fund
5.97%9.43%32.28%6.76%4.94%0.66%0.00%0.00%0.00%0.00%0.00%0.00%
MELIX
Morgan Stanley Institutional Fund, Inc. Emerging Markets Leaders Portfolio
0.00%0.00%0.00%0.00%0.00%0.08%4.04%6.90%0.47%0.97%0.12%1.30%

Frequently Asked Questions


MELIX and GMAQX have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GMAQX has higher volatility (12.47%) compared to MELIX (6.40%). In terms of maximum drawdown, MELIX dropped -46.84% vs GMAQX's -41.97%.

GMAQX currently has the higher Sharpe Ratio (4.51 vs 1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MELIX and GMAQX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer